Skip to main content
. Author manuscript; available in PMC: 2009 Sep 9.
Published in final edited form as: Circ Res. 2009 Apr 2;104(9):1058–1065. doi: 10.1161/CIRCRESAHA.109.194506

Figure 2.

Figure 2

Exogenous adiponectin reduces pathological vessel formation in ischemic retina. A, Adenovirus-mediated supplementation of adiponectin attenuates pathological retinal neovascularization in APN-KO and WT mice. Adenoviral vectors expressing adiponectin (Ad-APN) (4×107 pfu total, n=10) or β-galactosidase (Ad-βgal) (control, n=10) were delivered intravenously via the jugular vein at P10. B, Administration of adiponectin protein reduces retinal neovascularization in APN-KO and WT mice. Recombinant APN protein (rAPN) (3.0 μg/g body weight) (n=9 to 10) or vehicle (n=9) was intraperitoneally injected into APN-KO and WT mice daily from P12 to P 17. Data are presented as means±SEM.